摘要
近年来随着影像、放疗技术及分子靶向治疗的研究,使得作为头颈部鳞状细胞癌(head and neck squamous cell carcinoma,HNSCC)三大传统治疗方式之一的放疗得到了发展。
出处
《中国中西医结合耳鼻咽喉科杂志》
2015年第4期317-320,316,共5页
Chinese Journal of Otorhinolaryngology in Integrative Medicine
基金
泸州医学院附属医院留学归国人员科研项目(2013-60-2)
四川省应用基础研究项目(14JC0182)
参考文献32
-
1Bhide SA, Newbold KL, Harrington KJ, et al. Clinical eval- uation of intensity- modulated radiotherapy for head and neck cancers[J]. Br J Radiol, 2012, 85(1013): 487-494.
-
2Lee N, Xia P, Quivey JM, et ah Intensity modulated radio- therapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience[J], lnt J Radiat Oneol Biol Phys, 2002, 53(1): 12-22.
-
3Zong J, Lin S, Lin J, et al. Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma:Validation of the 7th edition AJCC staging system [J]. Oral Oncol, 2015,51(3):254-259.
-
4Wirth LJ, Alien AM, Posner MR, et al. Phase I dose- finding study of paclitaxel with panitumumab,carboplatin and intensity modulated radiotherapy in patients with lo- cally advanced squamous cell cancer of the head and neck[J]. Ann Oncol, 2010, 21(2): 342-347.
-
5Nutting CM, Morden JP, Harrington KJ, et al.Parotid-spar- ing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase3 muhicen- tre randomised controlled tria [J]. Lancet Oneol, 2011, 12 (2): 127-136.
-
6Chen YY, Zhao C, Wang J, et al. Intensity-modulated ra- diotherapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: a prospective study with >5 years of follow-up [J]. Cancer, 2011, 117 (13): 2910- 2916.
-
7Peng G, Wang T, Yang KY, et al. A prospective random- ized study comparing outcomes and toxicities of intensity- modulated Radiotherapy vs conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcino- ma Radiotherapy [J]. Radiother Oneol, 2012, 104(3): 286- 293.
-
8Lai SZ, Li WF, Chen L, et al. How does intensity modu- lated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopha- ryngeal carcinoma patients [J]. Int J Radiat Oneol Biol Phys, 2011, 80(3): 661-668.
-
9Lee AW, Sze WM, Yau TK, et al. Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fraetionation(6 fractions per week) in comparison with con- ventional fractionation (5 fractions per week):report on 3- years tumor control and normal tissue toxicity [J]. Radio- ther oncol, 2001, 58(2): 121-130.
-
10Lee AW, Tung SY, Chan AT, et al. A randomized trial on addition of concurrent adjuvant chemotherapy and/or ac- celerated fractionation for locally-advanced nasopharyn- geal carcinoma [J]. Radiother oncol, 2011, 98(1): 15-22.
二级参考文献20
-
1XIE Minqiang,CHEN Shuaijun,XU Xueqing,LI Zhonghan,SHEN Hui,XU Jiarui.Preparation of two kinds of superparamagnetic carriers-supported cis-platinum complexes and the compari-son of their characteristics[J].Chinese Science Bulletin,2006,51(2):151-157. 被引量:11
-
2Xing L ,Radiother Oncol,2000年,56卷,97页
-
3Lin Z X ,Int J Radiat Oncol Biol Phys,1998年,42卷,suppl期,368页
-
4Yu C X,Phys Med Biol,1995年,40卷,1435页
-
5Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma:an update of the USCF experience [J]. Int J Radiat Oncol Biol Phys, 2002, 53(1): 12-22.
-
6Lin S, Pan J, Lu H, et al. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated therapy:report on the 3-years outcome of a prospective series[J]. Int J Radiat Oncol Biol Phys, 2009, 75(4): 1071-1078.
-
7Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc[J]. Med Phys, 2008, 35( 1 ) : 310-317.
-
8Wang J, Bai S, Chen N, et al. The clinical feasibility and effect of online cone beam computer tomography- guided intensity -modulated radiotherapy fornasopharyngeal cancer [J]. Radiother Oncol, 2009, 90 (2) : 221-217.
-
9Den RB, Doemer A, Kubicek G, et al. Daily image guidance with cone-beam computed tomography for head -and neck cancer intensity -modulated radiotherapy: a prospective study [J ]. Int J Radiat Oncol Biol Phys, 2010, 76(5) : 1353-1359.
-
10Van Herk M, Remeijer P, Rasch C, et al. The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy [J]. Int J Radiat Oncol Biol Phys, 2000, 47 (4) : 1121-1135.
共引文献37
-
1余党凡,左传涛,戴嘉中,董孟杰,赵军,林祥通,管一晖.FDG-PET/CT在鼻咽癌放疗后随访中的初步应用研究[J].癌症,2004,23(z1):1538-1541. 被引量:7
-
2刘生,梁碧玲,蒋宁一,邹德环,朱旭生,薛卫平.^(18)F-FDG SPECT/CT显像在鼻咽癌诊断及分期中的价值[J].中山大学学报(医学科学版),2005,26(3):341-346. 被引量:4
-
3方小勇,杨志祥,杨文峰.CT模拟与三维计划对减低鼻咽癌放疗并发症的价值[J].中国现代医学杂志,2006,16(8):1238-1241. 被引量:3
-
4刘生,许泽清,梁培炎,朱旭生,蒋宁一,卢献平,梁九根.^(18)F-FDG SPECT/CT符合显像在鼻咽癌患者中的临床应用[J].中国热带医学,2006,6(9):1563-1565.
-
5彭齐荣,张罗生,张红梅,贾彦征,段宇新,高兴旺.43例鼻咽癌的调强适形放射治疗体会[J].现代肿瘤医学,2007,15(3):320-322. 被引量:4
-
6田桂英,王翠兰,熊伟.鼻咽癌常规放疗与后程适形放疗效果分析[J].中国煤炭工业医学杂志,2007,10(5):571-572. 被引量:4
-
7黄江琼,王安宇.^(18)F-FDG PET对鼻咽癌诊断和治疗影响的研究进展[J].中华肿瘤防治杂志,2007,14(13):1033-1036. 被引量:1
-
8王程鹏,杨晋,杨海英.适形调强放射治疗鼻咽癌56例体会[J].海军医学杂志,2007,28(3):207-209. 被引量:1
-
9李星,周丽华,倪泽罡.常规放疗加后程三维适形放射治疗鼻咽癌的近期疗效观察[J].医学临床研究,2009,26(2):271-273.
-
10曹诗林,李莹,徐坚民,单军,朱进,胡丽霞.磁共振扩散加权成像在评估鼻咽癌放射治疗中的应用[J].实用放射学杂志,2010,26(6):795-799. 被引量:13
同被引文献2
-
1李丽娟,温树信,王斌全,高伟,张文,孟晓敏,杨丽娟,孔令帅.肿瘤干细胞标记物USP22蛋白在喉鳞状细胞癌中的表达及预后分析[J].中华耳鼻咽喉头颈外科杂志,2014,49(6):479-482. 被引量:10
-
2张从红,冯华君,周春玲,王丁婷,赵飞鹏,赵冲,许胜恩,覃纲.基于生物信息学方法鉴定头颈部鳞状细胞癌的关键基因及信号通路[J].中国中西医结合耳鼻咽喉科杂志,2019,27(5):372-378. 被引量:2
-
1张骏,李勇,姒健敏.生长抑素受体介导的靶向放疗与消化系肿瘤治疗[J].中华消化杂志,2004,24(4):254-256. 被引量:1
-
2林森.大剂量靶向放疗有利于不能手术的肺癌患者[J].中华医学信息导报,2004,19(3):6-6.
-
3郭宏华,张建忠,王江滨.生长抑素受体介导的靶向放疗在消化系统肿瘤治疗中的研究进展[J].国际内科学杂志,2007,34(8):475-478.
-
4高双,徐雷鸣.晚期胰腺癌治疗的研究进展[J].胃肠病学,2012,17(11):699-702. 被引量:2
-
5张骏,姒健敏,梅彦,李勇,崔盈,王凡,贾宾.生长抑素受体介导^(90)Y-DOTA-Octreotide靶向抗肿瘤效应初探[J].实用肿瘤学杂志,2006,20(3):196-198. 被引量:1
-
6刘弦,黄桂林.头颈部恶性肿瘤前哨淋巴结的研究进展[J].遵义医学院学报,2013,36(2):180-183.
-
7江飞,陈宁.环氧化酶-2与头颈部鳞癌的相关研究进展[J].口腔生物医学,2010,1(1):37-39.
-
8王健,王秀问.生长抑素受体显像和治疗研究进展[J].中华核医学杂志,2011,31(3):213-216. 被引量:4
-
9王莹颖,华清泉,张志坚.CD44、CD133在头颈部鳞状细胞癌中的表达及临床意义[J].现代预防医学,2010,37(11):2147-2149. 被引量:2
-
10孙青,华瑛,谢瑶,赵卫红,吴鹏辉,李硕,卢新天.儿童神经母细胞瘤综合治疗疗效分析[J].中国小儿血液与肿瘤杂志,2015,20(5):251-255. 被引量:6